Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on November 1, 2007

Arteriosclerosis, Thrombosis, and Vascular Biology. 2007
Published online before print November 1, 2007, doi: 10.1161/ATVBAHA.107.155499
A more recent version of this article appeared on January 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
28/1/105    most recent
ATVBAHA.107.155499v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miao, R. Q.
Right arrow Articles by Sessa, W. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miao, R. Q.
Right arrow Articles by Sessa, W. C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NITRIC OXIDE
Related Collections
Right arrowRelated Article

Submitted on February 7, 2007
Accepted on October 23, 2007

Dominant-Negative Hsp90 Reduces VEGF Stimulated Nitric Oxide Release and Migration in Endothelial Cells

Robert Q. Miao ; Jason Fontana ; David Fulton ; Michelle I. Lin ; Kenneth D. Harrison ; and William C. Sessa *

From the Department of Pharmacology and Vascular Biology & Therapeutics Program, Boyer Center for Molecular Medicine, Yale University School of Medicine, New Haven, Conn.

* To whom correspondence should be addressed. E-mail: william.sessa{at}yale.edu.

Objectives—Heat-shock protein 90 (Hsp90) coordinates the regulation of diverse signaling proteins. We try to develop a new tool to explore the regulatory functions of Hsp90 in endothelial cells (ECs) instead of the existing chemical approaches.

Methods and Results—We designed a dominant-negative Hsp90 construct by site-direct mutagenesis of residue Asp-88 to Asn (D88N-Hsp90) based on the structure of the ATP/ADP-binding site. Recombinant wild-type Hsp90 protein binds ATP-Sepharose beads in manner inhibited by ATP or 17-AAG, a specific inhibitor for Hsp90, however the binding activity of D88N-Hsp90 was markedly reduced and the inhibitory effects of ATP or 17-AAG were negligible. The dimerization between endogenous Hsp90{alpha} and exogenous HA-Hsp90{beta} was confirmed by immunoprecipitation, however the association between eNOS and D88N-Hsp90 was less than WT-Hsp90. Furthermore, adenoviral transduction of bovine aortic ECs with D88N-Hsp90 suppressed VEGF-induced phosphorylation of Akt, eNOS, and NO release and the inhibitory effect was blocked by okadaic acid. Moreover, D88N-Hsp90 abolished VEGF-stimulated Rac activation and suppressed VEGF-induced stress fiber formation. Transduction with D88N-Hsp90 decreased growth medium mediated migration of wild-type ECs, but not Akt1(-/-) ECs suggesting that Akt is key target of Hsp90.

Conclusions—Our data demonstrate that dominant-negative Hsp90 modulates endothelial cell mobility mainly through PP2A-mediated dephosphorylation of Akt and Rac activation.


Key words: Hsp90 • ATP-binding • Akt • migration • dominant-negative


Related Article:

Twin Layers of Lightning: A New Role for the Chaperone Hsp90 in Angiogenesis
Xinchun Pi and Cam Patterson
Arterioscler Thromb Vasc Biol 2008 28: 6-7. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Mol Cancer ResHome page
B. Annamalai, X. Liu, U. Gopal, and J. S. Isaacs
Hsp90 Is an Essential Regulator of EphA2 Receptor Stability and Signaling: Implications for Cancer Cell Migration and Metastasis
Mol. Cancer Res., July 1, 2009; 7(7): 1021 - 1032.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. Mohan, R. Konopinski, B. Yan, V. E. Centonze, and M. Natarajan
High glucose-induced IKK-Hsp-90 interaction contributes to endothelial dysfunction
Am J Physiol Cell Physiol, January 1, 2009; 296(1): C182 - C192.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Wang, Q. Peng, J. Zhang, and L. Liu
Na+/H+ exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain
Cardiovasc Res, November 1, 2008; 80(2): 255 - 262.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. Shankar, Q. Chen, S. Ganapathy, K. P. Singh, and R. K. Srivastava
Diallyl trisulfide increases the effectiveness of TRAIL and inhibits prostate cancer growth in an orthotopic model: molecular mechanisms
Mol. Cancer Ther., August 1, 2008; 7(8): 2328 - 2338.
[Abstract] [Full Text] [PDF]